Literature DB >> 7952870

Study of the effector mechanism involved in the production of haemorrhagic necrosis of the small intestine in rat passive anaphylaxis.

M I Pellón1, A A Steil, V Furió, M Sánchez Crespo.   

Abstract

1. The effector mechanism of intestinal necrosis in rat anaphylaxis was studied following several complementary approaches: (i) the use of monoclonal antibodies (mAb) belonging to different classes (IgG1, IgG2b and IgE anti-DNP), (ii) the assay of mediators, and (iii) the use of pharmacological tools. 2. Lethality and haemorrhagic necrosis of the small intestine were observed in IgE-sensitized rats, whereas IgG mAb produced milder physiological disturbances. 3. Inhibition of leukotriene biosynthesis reduced the drop of systemic blood pressure (BP) and the extent of protein-rich plasma exudation but it did not influence the haemorrhagic component of intestinal necrosis. 4. The antihistamine, pyrilamine, partially diminished the haemorrhagic component of the intestinal necrosis. 5. The involvement of mediators related to platelet-activating factor (PAF) was studied by examining the pharmacological effects of these autacoids and of PAF-receptor antagonists (PCA4248, UR12460 and BB823). PAF induced intestinal lesions similar to those observed in IgE-sensitized rats and PAF-receptor antagonists markedly decreased haemorrhage in IgE-sensitized rats. 6. PAF levels were transiently increased after dinitrophenol (DNP)- bovine serum albumin (BSA) challenge in the small intestine of IgE-sensitized rats. 7. These data stress differences in the outcome of anaphylaxis related to the type of receptors for the Fc portion of immunoglobulins that are involved. IgE is the antibody class that elicits the most severe response due to the activation of mast cells via Fc epsilon RI (surface receptors that bind IgE antibodies with high affinity), and the only one able to produce intestinal haemorrhagic necrosis. 8. The mast-cell-derived mediators PAF/acyl-PAF and histamine, most probably associated with tumour necrosis factor alpha/cachectin (TNF-alpha), seem to play a central role in the production of the vascular changes required for the extravasation of erythrocytes in the small intestine mucosa.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7952870      PMCID: PMC1910267          DOI: 10.1111/j.1476-5381.1994.tb13197.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  53 in total

1.  Intestinal lesions following histamine liberation in the rat.

Authors:  B F FELL; R BOYNE; D P CUTHBERTSON
Journal:  J Pathol Bacteriol       Date:  1961-10

2.  Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor.

Authors:  X M Sun; W Hsueh
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

3.  Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells.

Authors:  M Triggiani; R P Schleimer; J A Warner; F H Chilton
Journal:  J Immunol       Date:  1991-07-15       Impact factor: 5.422

4.  Secretory granule mediator release and generation of oxidative metabolites of arachidonic acid via Fc-IgG receptor bridging in mouse mast cells.

Authors:  H R Katz; M B Raizman; C S Gartner; H C Scott; A C Benson; K F Austen
Journal:  J Immunol       Date:  1992-02-01       Impact factor: 5.422

5.  Improved high-performance liquid chromatographic method for isolation of platelet-activating factor from other phospholipids.

Authors:  M L Blank; F Snyder
Journal:  J Chromatogr       Date:  1983-04-08

6.  Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine.

Authors:  D M Humphrey; L M McManus; D J Hanahan; R N Pinckard
Journal:  Lab Invest       Date:  1984-01       Impact factor: 5.662

7.  Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether.

Authors:  M Sánchez-Crespo; S Fernández-Gallardo; M L Nieto; J Baranès; P Braquet
Journal:  Immunopharmacology       Date:  1985-10

8.  Biosynthesis of platelet activating factor and 1-O-acyl analogues by endothelial cells.

Authors:  K L Clay; C Johnson; G S Worthen
Journal:  Biochim Biophys Acta       Date:  1991-08-13

9.  Acute inflammation and a Shwartzman-like reaction induced by interleukin-1 and tumor necrosis factor. Synergistic action of the cytokines in the induction of inflammation and microvascular injury.

Authors:  H Z Movat; C E Burrowes; M I Cybulsky; C A Dinarello
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

10.  Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin.

Authors:  J R Gordon; S J Galli
Journal:  Nature       Date:  1990-07-19       Impact factor: 49.962

View more
  7 in total

1.  Platelet-activating factor increases mucosal permeability in rat intestine via tyrosine phosphorylation of E-cadherin.

Authors:  X D Tan; H Chang; X W Qu; M Caplan; F Gonzalez-Crussi; W Hsueh
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

2.  Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumour necrosis factor.

Authors:  H Wang; X Tan; H Chang; F Gonzalez-Crussi; D G Remick; W Hsueh
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

3.  Induction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factor.

Authors:  Zhili Xu; Jeffrey S Smith; Jie Tian; Andrew P Byrnes
Journal:  Mol Ther       Date:  2009-12-01       Impact factor: 11.454

4.  Platelet-activating factor: the effector of protein-rich plasma extravasation and nitric oxide synthase induction in rat immune complex peritonitis.

Authors:  A A Steil; M C Garcia Rodriguez; A Alonso; M S Crespo; L Bosca
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

5.  Anaphylactoid Reaction from IV Contrast Dye Causing Ischemic Colitis with Portal Venous Gas.

Authors:  Adeleke Adesina; Adam Colombo; Rebecca Jeanmonod
Journal:  Case Rep Crit Care       Date:  2015-04-23

6.  Quinidine, but not eicosanoid antagonists or dexamethasone, protect the gut from platelet activating factor-induced vasoconstriction, edema and paralysis.

Authors:  Ingmar Lautenschläger; Inéz Frerichs; Heike Dombrowsky; Jürgen Sarau; Torsten Goldmann; Karina Zitta; Martin Albrecht; Norbert Weiler; Stefan Uhlig
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

7.  Nitric oxide decreases intestinal haemorrhagic lesions in rat anaphylaxis independently of mast cell activation.

Authors:  J C Tavares; A Moreno; M S Crespo
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.